Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Wright CJ, Kirpalani H.

Pediatrics. 2011 Jul;128(1):111-26. doi: 10.1542/peds.2010-3875. Epub 2011 Jun 6. Review.

2.

Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.

Bassler D.

Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Review.

PMID:
26044104
3.

Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.

Nold MF, Mangan NE, Rudloff I, Cho SX, Shariatian N, Samarasinghe TD, Skuza EM, Pedersen J, Veldman A, Berger PJ, Nold-Petry CA.

Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14384-9. doi: 10.1073/pnas.1306859110. Epub 2013 Aug 14.

4.

Pathogenesis and treatment of bronchopulmonary dysplasia.

Gien J, Kinsella JP.

Curr Opin Pediatr. 2011 Jun;23(3):305-13. doi: 10.1097/MOP.0b013e328346577f. Review.

5.

Pathogenesis of bronchopulmonary dysplasia.

Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM.

Semin Perinatol. 2006 Aug;30(4):171-8. Review.

PMID:
16860156
6.

Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia.

Ambalavanan N, Carlo WA.

Semin Perinatol. 2006 Aug;30(4):192-9. Review.

PMID:
16860159
7.

[From classic to new bronchopulmonary dysplasia].

Kramer BW, Lievense S, Been JV, Zimmermann LJ.

Ned Tijdschr Geneeskd. 2010;154:A1024. Review. Dutch.

PMID:
20456770
8.

Mechanisms initiating lung injury in the preterm.

Jobe AH, Ikegami M.

Early Hum Dev. 1998 Nov;53(1):81-94. Review.

PMID:
10193929
9.

Stem cells for the prevention of neonatal lung disease.

O'Reilly M, Thébaud B.

Neonatology. 2015;107(4):360-4. doi: 10.1159/000381135. Epub 2015 Jun 5. Review.

PMID:
26044105
10.

[Advances in bronchopulmonary dysplasia].

Liao LJ, Luo XP.

Zhonghua Er Ke Za Zhi. 2004 Mar;42(3):231-3. Review. Chinese. No abstract available.

PMID:
15144727
11.

Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration.

Baker CD, Alvira CM.

Curr Opin Pediatr. 2014 Jun;26(3):306-14. doi: 10.1097/MOP.0000000000000095. Review.

12.

Ureaplasma and bronchopulmonary dysplasia.

Gancia P, Delogu A, Pomero G.

Early Hum Dev. 2014 Mar;90 Suppl 1:S39-41. doi: 10.1016/S0378-3782(14)70013-1. Review.

PMID:
24709455
13.

[Strategies to minimize lung injury in extremely low birth weight infants].

Suguihara C, Lessa AC.

J Pediatr (Rio J). 2005 Mar;81(1 Suppl):S69-78. Review. Portuguese.

14.

Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants.

Schulzke SM, Kaempfen S, Patole SK.

Cochrane Database Syst Rev. 2014 Nov 24;(11):CD010018. doi: 10.1002/14651858.CD010018.pub2. Review.

PMID:
25418278
15.

Predictors of bronchopulmonary dysplasia.

Trembath A, Laughon MM.

Clin Perinatol. 2012 Sep;39(3):585-601. doi: 10.1016/j.clp.2012.06.014. Review.

16.

Cell therapy: a novel treatment approach for bronchopulmonary dysplasia.

Vosdoganes P, Lim R, Moss TJ, Wallace EM.

Pediatrics. 2012 Oct;130(4):727-37. doi: 10.1542/peds.2011-2576. Epub 2012 Sep 3. Review.

PMID:
22945412
17.

Ureaplasma and BPD.

Kallapur SG, Kramer BW, Jobe AH.

Semin Perinatol. 2013 Apr;37(2):94-101. doi: 10.1053/j.semperi.2013.01.005. Review.

18.

Growth factors, stem cells and bronchopulmonary dysplasia.

Alphonse RS, Thébaud B.

Neonatology. 2011;99(4):326-37. doi: 10.1159/000326621. Epub 2011 Jun 23. Review.

PMID:
21701205
19.

Bronchopulmonary dysplasia: a review.

Ali Z, Schmidt P, Dodd J, Jeppesen DL.

Arch Gynecol Obstet. 2013 Aug;288(2):325-33. doi: 10.1007/s00404-013-2753-8. Epub 2013 Feb 19. Review.

PMID:
23420126
20.

Azithromycin and other macrolides for prevention of bronchopulmonary dysplasia: a systematic review and meta-analysis.

Nair V, Loganathan P, Soraisham AS.

Neonatology. 2014;106(4):337-47. doi: 10.1159/000363493. Epub 2014 Oct 1. Review.

Supplemental Content

Support Center